Clinical characteristics, outcomes and predictors of progression to multiple myeloma (MM) in 61 patients with solitary plasmacytoma von Manasanch, E.E, Claussen, C.M, Dong, W, Shah, J, Lee, H, Thomas, S, Reed, V.K, Dabaja, B.S, Milgrom, S, Pinnix, C.C, Parmar, S, Shah, N, Patel, K, Bashir, Q, Qazilbash, M, Orlowski, R, Feng, L, Weber, D

Volltext

Hyperfractionated Cyclophosphamide and Dexamethasone Alone or in Combination with Daratumumab and/or Carfilzomib for the Treatment of Relapsed or Refractory Multiple Myeloma: A Sin... von Shank, B.R., Primeaux, B., Yeung, E.K., Horowitz, S.B., Lee, I.Y., Roccograndi, L., Feng, L., Kaufman, G.P., Lee, H.C., Manasanch, E.E., Patel, K.K., Orlowski, R.Z., Weber, D.M., Becnel, M.R., Thomas, S.K.

Volltext

Involved Site and Reduced Dose Radiation Therapy for Multiple Myeloma: Should It be the New Standard? von Elhammali, A., Gunther, J.R., Milgrom, S.A., Pinnix, C.C., Andraos, T., Weber, D., Orlowski, R., Manasanch, E.E., Patel, K., Lee, H., Thomas, S., Amini, B., Garg, N., Dabaja, B.

Volltext

The Impact of PET-CT on Rates of Progression from Solitary Plasmacytoma to Multiple Myeloma after Definitive Radiation Therapy von Anakwenze, C.P., Gunther, J.R., Manasanch, E.E., Noticewala, S.S., Milgrom, S.A., Lee, H., Patel, K., Thomas, S., Iyer, S.P., Weber, D., Park, C., Amini, B., Khoury, J., Medeiros, L.J., Orlowski, R., Dabaja, B., Pinnix, C.C.

Volltext

Involved Site vs Extended Field Radiation Therapy for Multiple Myeloma of Long Bones after Internal Fixation von Elhammali, A., Dabaja, B., Gunther, J.R., Yoder, A.K., Moon, B., Weber, D., Thomas, S., Andraos, T., Garg, N., Amini, B., Manasanch, E.E., Patel, K., Orlowski, R., Lee, H., Bird, J., Satcher, R., Lin, P., Pinnix, C.C., Milgrom, S.A.

Volltext

High-dose therapy with auto-SCT is feasible in high-risk cardiac amyloidosis von Kongtim, P, Qazilbash, M H, Shah, J J, Hamdi, A, Shah, N, Bashir, Q, Wang, M, Champlin, R, Manasanch, E E, Weber, D, Orlowski, R Z, Parmar, S

Volltext

PS1389 IMPACT OF DIFFERENT MAINTENANCE THERAPY OPTIONS AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA AT MD ANDERSON CANCER CENTER von El Shazly, M., Belal, A.A., Farouk, M., Srour, S., Popat, U., Kebriaei, P., Patel, K., Mehta, R.S., Lee, H.C., Manasanch, E.E., Orlowski, R., Champlin, R., Qazilbash, M., Bashir, Q.

Volltext